GPCR binding proteins and synthesis thereof

US11407837B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11407837-B2
Application numberUS-201816128372-A
CountryUS
Kind codeB2
Filing dateSep 11, 2018
Priority dateSep 11, 2017
Publication dateAug 9, 2022
Grant dateAug 9, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods and compositions relating to G protein-coupled receptor (GPCR) libraries having nucleic acids encoding for a scaffold comprising a GPCR binding domain. Libraries described herein include variegated libraries comprising nucleic acids each encoding for a predetermined variant of at least one predetermined reference nucleic acid sequence. Further described herein are protein libraries generated when the nucleic acid libraries are translated. Further described herein are cell libraries expressing variegated nucleic acid libraries described herein.

First claim

Opening claim text (preview).

What is claimed is: 1. A nucleic acid library comprising a plurality of nucleic acids, wherein each nucleic acid comprises: a) a nucleic acid sequence comprising a length of about 80 to about 230 base pairs that encodes for a CDR-H3 loop, wherein the CDR-H3 loop comprises a sequence of any one of SEQ ID NOs: 2420 to 2436; and b) a nucleic acid sequence encoding a variable domain of light chain (VL), wherein the nucleic acid sequence comprises at least about 90% sequence identity to any one of SEQ ID NOs: 94, 96, 98, 283, 301, 321, 416, 432, 459, 460, 616, 618, 647, 652, 660, 666, 677, 745, 755, 1627, 1883, and 2043, wherein each of the nucleic acids encodes for a sequence that when translated encodes for an immunoglobulin scaffold that comprises a GLP1R binding domain, and wherein the GLP1R binding domain is a ligand for GLP1R. 2. The nucleic acid library of claim 1 , wherein the immunoglobulin scaffold further comprises one or more domains selected from variable domain of heavy chain (VH), constant domain of light chain (CL), and constant domain of heavy chain (CH). 3. The nucleic acid library of claim 2 , wherein a length of the VH domain is about 280 to about 300 base pairs. 4. The nucleic acid library of claim 1 , wherein a length of the VL domain is about 90 to about 120 amino acids. 5. The nucleic acid library of claim 1 , wherein a length of the VL domain is about 300 to about 350 base pairs. 6. The nucleic acid library of claim 1 , wherein the library comprises at least 10 5 non-identical nucleic acids. 7. The nucleic acid library of claim 1 , wherein the immunoglobulin scaffold comprises a single immunoglobulin domain. 8. The nucleic acid library of claim 1 , wherein the immunoglobulin scaffold comprises a peptide of at most 100 amino acids. 9. The nucleic acid library of claim 1 , wherein the nucleic acid sequence encoding a variable domain of light chain (VL) comprises a sequence having at least about 90% sequence identity to SEQ ID NOs: 94, 96, and 98. 10. The nucleic acid library of claim 1 , wherein the nucleic acid sequence encoding a variable domain of light chain (VL) comprises a sequence having at least about 90% sequence identity to any one of SEQ ID NOs: 616, 618, 647, 652, 660, 666, 677, 745, and 755.

Assignees

Inventors

Classifications

  • against hormone receptors (for antibodies against neuromediator receptors C07K16/286) · CPC title

  • Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin C07K19/00) · CPC title

  • Preparation or screening of libraries displayed on scaffold proteins · CPC title

  • C07K16/005Primary

    constructed by phage libraries · CPC title

  • Complementarity determining region [CDR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11407837B2 cover?
Provided herein are methods and compositions relating to G protein-coupled receptor (GPCR) libraries having nucleic acids encoding for a scaffold comprising a GPCR binding domain. Libraries described herein include variegated libraries comprising nucleic acids each encoding for a predetermined variant of at least one predetermined reference nucleic acid sequence. Further described herein are pr…
Who is the assignee on this patent?
Twist Bioscience Corp
What technology area does this patent fall under?
Primary CPC classification C07K16/2869. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).